Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP

Rank in Stocks #11772
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$6.89
Last synced: 2026-11-18
Market Cap
$503.43M
Change (1 day)
-4.31%
Change (1 year)
-
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Earnings for Cybin Inc. Common Stock (HELP)
Earnings in Jun 2026 TTM: $-183.27M
According to Cybin Inc. Common Stock's latest financial reports, its current earnings (TTM) are $-183.27M. In 2025 the company earned $-78.95M, a decrease compared to its 2024 earnings of $-57.70M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Cybin Inc. Common Stock from 2017 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-183.27M 132.14%
2025 $-78.95M 36.82%
2024 $-57.70M 63.49%
2023 $-35.29M -34.93%
2022 $-54.24M 111.52%
2021 $-25.64M 1,757.28%
2020 $-1.38M 1,703.78%
2019 $-76.54K -54.87%
2018 $-169.58K 67.02%
2017 $-101.54K 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$4.76B -2,697.04%
US
$-2.73B 1,389.09%
US
$-4.02B 2,091.46%
AU
$2.79B -1,624.21%
BE
$1.50B -916.81%
NL

Questions about Cybin Inc. Common Stock's net income

What is Cybin Inc. Common Stock's net income?

Cybin Inc. Common Stock's net income over the last twelve months is $-183.27M, as of Jun 2026.

What was Cybin Inc. Common Stock's net income in 2025?

In 2025, Cybin Inc. Common Stock's net income was $-78.95M, compared with $-57.70M in 2024.

How has Cybin Inc. Common Stock's net income changed since 2020?

From 2020 to 2025, Cybin Inc. Common Stock's net income was highest in 2020 ($-1.38M) and lowest in 2025 ($-78.95M).

How does Cybin Inc. Common Stock's net income compare with similar companies?

Cybin Inc. Common Stock's net income ($-183.27M) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.